Further studies are needed to establish optimal treatment parameters, but these early results suggest that cryolipolysis will likely be best suited for localized fat removal in areas that are particularly resistant to exercise, he said.
Despite the apparent promise of the new technologies, Dr. Avram was quick to stress that the "clear but limited noninvasive fat removal achieved with these devices is in no way, shape, or form a competitor for liposuction." They are noninvasive alternatives that can achieve certain results, which should be made clear to patients.
Dr. Avram has conducted research for Candela Corp. and owns stock options in Zeltiq Aesthetics, which holds the cryolipolysis patent.